The CMS BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive Health) pilot program, announced in December 2025, aims to begin expanding Medicare access to obesity medications by mid-2026, with a broader Part D model rolling out in January 2027
Your peak performance is not a thing of the past
Glutathione GLUTATHIONE is a wonder drug
Weekly weigh-ins at the same time of day provide more useful data than daily fluctuations
Healthcare professionals and patients are encouraged to consult up-to-date resources from the MHRA, NICE, and NHS England, and to monitor peer-reviewed literature for evolving evidence on this promising but still investigational therapy
In head-to-head trials, tirzepatide consistently outperformed semaglutide for weight loss